Kenya has officially launched the nationwide rollout of Lenacapavir (LEN), a new long-acting injectable drug for HIV prevention, on Thursday, February 27, 2026. This significant advancement offers a more convenient option alongside existing oral and injectable PrEP methods.

• The drug, administered once every six months, demonstrated up to 100 percent efficacy in clinical trials for women.
• The rollout is managed by the Ministry of Health through the National Aids and STIs Control Programme (Nascop).
• Clients must undergo a mandatory HIV test, weight screening, and disclose current medications (like TB drugs) to ensure eligibility and prevent drug resistance.

AMPATH Kenya has launched a new national breast cancer care initiative aimed at improving access to high-quality treatment and reducing the disease's burden across the country.

• The initiative, Integrated Model for Access, Retention and Advanced Breast Cancer Care, spans three years.
• Key figures include AMPATH Kenya and Principal Secretary for Medical Services, Dr. Ouma Oluga.
• The project will strengthen community awareness, healthcare worker capacity, service delivery, and patient navigation to reduce late-stage presentations and improve survival outcomes.

Kenya is seeking to enhance its digital health infrastructure and reduce maternal deaths by partnering with the World Bank. This initiative is a key focus for President William Ruto's administration.

• 29.6 million Kenyans have registered under the new Social Health Authority (SHA), a significant step towards universal health coverage.
• The key individuals involved are Kenya's Health Cabinet Secretary Aden Duale and a delegation from the World Bank.
• Kenya aims to achieve World Health Organisation (WHO) Maturity Level 3 certification by June 2026 to bolster its regulatory systems.